
John Oliver sued by healthcare boss he rebuked on air over ‘bowel movement' comments
Dr. Brian Morley, a hospital administrator and former medical director for AmeriHealth Caritas in Iowa, filed his lawsuit Friday in the U.S. District Court for the Southern District of New York. Morley's complaint stems from a Medicaid-themed episode of 'Last Week Tonight' that aired in April 2024. The lawsuit, reviewed by The Times, alleges Oliver and 'Last Week Tonight' producer Partially Important Productions linked Morley to a drastic decrease in Medicaid services and accused him of thinking 'it's ok if people have s— on them for days.'
An attorney for Morley did not comment to The Times on Wednesday and a representative for Oliver did not immediately respond to a request for comment.
The episode central to Morley's lawsuit aired April 14, 2024, and saw Oliver explore the state of Medicaid, examining healthcare companies' cost-cutting measures and their toll on patients across various states. During the segment, which aired on HBO and is available on YouTube, Oliver explained the role of managed care organizations (MCOs) in the healthcare system and shared a news outlet's video about dwindling patient care. The 2018 news snippet featured a cerebral palsy patient in Iowa named Louis whose care was negatively impacted by MCO involvement.
Oliver followed that part of the segment with an audio snippet of Morley's comments about patient care from a 2017 administrative hearing. In the clip, Morley can be heard saying: 'People have bowel movements every day where they don't completely clean themselves and we don't fuss over [them] too much. People are allowed to be dirty. You know, I would allow him to be a little dirty for a couple of days.'
The quote garnered a strong reaction from the 'Last Week Tonight' studio audience and led Oliver to say he thought Morley's comments were taken out of context. He explained that he first thought 'there is no way a doctor, a licensed physician, would testify in a hearing that he thinks it's OK if people have s— on them for days.' Oliver continued his segment stating his team obtained the full hearing and that Morley 'said it.'
'He meant it and it made me want to punch a hole in the wall,' Oliver said. The segment returned to the 2018 video of Louis and his mother, both responding negatively to Morley's comments. The 'Last Week Tonight' host had some choice words for Morley — which were cited in Friday's lawsuit.
In his complaint, Morley says, 'Defendants' false accusations were designed to spark outrage, and they did.
'The false accusations Defendants made were so heinous that John Oliver felt justified in telling his millions of viewers: 'F— that doctor with a rusty canoe. I hope he gets tetanus of the balls,'' the complaint said. 'Oliver's feigned outrage at Dr. Morley was fabricated for ratings and profits at the expense of Dr. Morley's reputation and personal well-being.'
Morley accused Oliver and 'Last Week Tonight' of making him the 'face' of the dramatic decrease in Medicaid care and increased cost-cutting. The lawsuit also raised concerns about how 'Last Week Tonight' allegedly misrepresented Morley's 2017 comments and 'knew and disregarded' various details of the hearing in the April episode.
The lawsuit alleges that the 'Last Week Tonight' team 'conveyed the false and defamatory meanings' that Morley denied care to 'Louis and/or the alleged 'similar' individual subject' of his testimony and that he allegedly said it was acceptable for patients who wear diapers or who cannot bathe themselves to 'be left sitting in their own bowel movements for days.'
The complaint says that the 'Last Week Tonight' team obtained and reviewed 'an unabridged audio recording' of the 2017 hearing and that one of the show's senior news producers allegedly confirmed to Morley that they had reviewed the hearing. According to the lawsuit, Morley made his 'bowel movement' comments in regard to a 'hypothetical average person, who is independently mobile and can toilet transfer' but who might not have been able to clean themselves entirely after a bowel movement. 'Last Week Tonight' allegedly did not disclose that detail, according to the lawsuit.
He accused the show's producers of 'negligence, knowledge of falsity, and/or a reckless disregard for the truth.'
Morely also alleges that a 'Last Week Tonight' news producer 'refused' to meet when he offered to explain his comments. The defendants also allegedly refused Morley's October 2024 request that they 'retract their false and defamatory statements.'
Morley seeks an unspecified amount in damages including legal fees and additional relief. He also requests that judges order 'Last Week Tonight' to remove the 'false and defamatory statements from all platforms' and keep them from republishing. He is seeking a trial.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Axios
3 hours ago
- Axios
States sue Trump admin over trans care access
Sixteen states and the District of Columbia are suing the Trump administration over what they charge is a coordinated federal effort to intimidate health care providers into stopping gender-affirming care for individuals under age 19. The big picture: The suit revolved around a January executive order President Trump issued and subsequent administration actions the states say amount to an attempt to enforce a nationwide ban on transition-related care. The latest: The administration actions are not only denying medically necessary care but coercing hospitals and doctors into violating anti-discrimination and other state laws, according to the complaint. The suit referenced Justice Department guidance threatening criminal prosecution of providers, investigations of hospitals, and demands for patient data. The states asked the court for an injunction, saying the actions were unlawful and intrude on their authority to enforce their own laws. The suit was filed in U.S. District Court in Massachusetts by attorneys general from California, Connecticut, Delaware, the District of Columbia, Hawai'i, Illinois, Maine, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New Mexico, New York, Rhode Island and Wisconsin. Pennsylvania Democratic Gov. Josh Shapiro was also listed as a plaintiff. Between the lines: While courts have temporarily blocked the administration from stripping federal funding from providers of gender-affirming medical services to minors, the Justice Department has taken other steps, including subpoenaing doctors for patient information. Meanwhile, the Federal Trade Commission has launched an inquiry into whether providers are making false claims about gender-affirming care's benefits or not disclosing risks. The efforts have prompted major hospitals to pause or shut down on transition-related services in states where they remain legal. "This reduction in services has caused significant harm to transgender adolescents in the Plaintiff States, depriving them of essential care at a critical time in their development," the states argue in the complaint. What they're saying:"The federal government is running a cruel and targeted harassment campaign against providers who offer lawful, lifesaving care to children," New York Attorney General Letitia James said in a statement. The White House last week claimed credit for making providers halt what it termed "child sexual mutilation," issuing a release listing more than a dozen health systems that stopped providing puberty blockers, hormone therapy and surgeries. "For years, politicians have promised to end the barbaric, pseudoscientific practice — but President Trump is the only one who has actually delivered," it said in a statement. About 40% of transgender youth live in the 27 states that already limit access to gender-affirming care for minors, according to KFF. Of those states, 17 currently face legal challenges to their policies.


American Military News
5 hours ago
- American Military News
Video/Pic: Trump demands drug companies lower prices
President Donald Trump sent 17 pharmaceutical companies letters on Thursday and demanded that the companies lower prices for Americans. The president warned that the 'unacceptable burden' of prescription drug prices will 'end' with his administration. During a press briefing on Thursday, White House Press Secretary Karoline Leavitt said, 'The president signed an executive order earlier this year to solve the problem of exorbitant pharmaceutical pricing.' 'According to recent data, the prices that Americans have been paying for brand-name drugs are more than three times the price other similarly developed nations pay,' Leavitt added. 'The president is determined to solve this problem and took further action today. He has signed 17 letters to pharmaceutical companies' CEOs.' .@PressSec reads one of the letters sent by @POTUS today to the CEOs of pharmaceutical companies: "Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices…" — Rapid Response 47 (@RapidResponse47) July 31, 2025 Leavitt also shared the letter Trump wrote to the CEO of Eli Lilly and Company. In the letter, Trump warned Eli Lilly and 16 other pharmaceutical companies that the 'unacceptable burden' of brand-name drugs costing 'up to three times higher on average' for Americans than for citizens of other countries 'ends with my administration.' Trump told the pharmaceutical companies, 'Most proposals the Trump administration has received to resolve this critical issue promised more of the same shifting blame and requesting policy changes that would result in billions of dollars in handouts to industry.' The president added, 'Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.' READ MORE: Video: Trump order against 'Big Pharma' aims to reduce drug prices While Trump explained that a collaborative effort to reach 'global pricing parity' would be most effective for pharmaceutical companies, the U.S. government, and U.S. patients, he warned that his administration will 'deploy every tool in our arsenal to protect American families' if pharmaceutical companies refuse to take action. In addition to the letter sent to Eli Lilly and Company, Trump sent letters to AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Genentech, Gilead Sciences, GSK, Johnson and Johnson, Merck, Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi. In the letters, Trump gave the companies 60 days to extend 'Most-Favored-Nation' pricing to Medicaid and provide 'full portfolios' of drugs for Medicaid patients, guarantee Most-Favored-Nation pricing for new drugs, negotiate with 'foreign freeloading nations' and return 'increased revenues abroad' to patients in the United States, and allow Americans to directly purchase drugs at Most-Favored-Nation prices. Today, @POTUS sent letters to 17 drug manufacturers outlining steps they must take to bring down prescription drug prices. If they refuse to step up, the Administration will use every tool to protect Americans from continued abusive drug pricing practices. Letter to Eli Lilly: — Rapid Response 47 (@RapidResponse47) July 31, 2025


Newsweek
6 hours ago
- Newsweek
California Removes 900,000 People From Health Care Plan
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hundreds of thousands have been removed from a health care plan in California over the course of two years, according to data from KFF, a nonprofit health policy research and news organization. About 900,000 Americans were disenrolled from Medicaid in the state as part of the unwinding process happening nationwide after Medicaid coverage was expanded following the COVID-19 pandemic. Newsweek has contacted the California Department of Public Health via email for comment. Why It Matters The unwinding process has resulted in significant drops in Medicaid enrollment across the U.S. There is now growing concern about the rising population of those without health insurance and the wider impacts this could have, such as worsening health outcomes, increasing strain on emergency services and rising medical costs. The worry has been amplified by the recent passing of President Donald Trump's One Big Beautiful Bill, in which funding cuts, a focus on "waste, fraud and abuse" and work requirements are in store for Medicaid. Many have voiced concern that the measures will result in millions losing health coverage. File photo: A doctor walks with a young boy through a hospital. File photo: A doctor walks with a young boy through a To Know In California, there were 14,285,643 covered by Medicaid in March 2023, but by March 2025, that number was 13,392,566, KFF data shows. This was because during the pandemic, some states expanded Medicaid coverage under the Affordable Care Act (ACA), causing nationwide enrollment levels to increase. Federal rules forced states to keep most Medicaid enrollees on the program, even if their eligibility status changed, until March 2023, when they were then allowed to start rolling recipients off the program. This marks a change of about 900,000, a decline that was smaller than other highly populated states like Texas, Florida and New York. In March 2025, the number of people with Medicaid coverage in California was still higher than pre-pandemic levels, by 16 percent. The reason why Medicaid coverage is unwinding at different rates in states is because "states approached the process of reviewing the eligibility of their Medicaid beneficiaries with fundamentally different strategies," Michael Sparer, professor and chair of the Department of Health Policy and Management at Columbia University, told Newsweek. He said that Florida and Texas began the review process "as fast as they could and immediately declared ineligible those beneficiaries who did not promptly respond to review notices." "There is clear evidence that many beneficiaries who were still eligible lost coverage simply because they did not timely navigate the administrative hurdles to recertification," he added. Meanwhile, he said that New York and California "were far more deliberate in how they approached the review process, thus the number who've lost their eligibility via this process is far fewer." What People Are Saying Michael Sparer, professor and chair of the Department of Health Policy and Management at Columbia University, told Newsweek: "Medicaid enrollment surged during the pandemic for several reasons, including increased unemployment combined with a requirement that in exchange for additional federal funding, states could not recertify beneficiary eligibility until the "public health emergency" was declared over. Put simply, millions signed up during the pandemic and their eligibility could only be reviewed beginning in the spring 2023. "There is reason to be quite concerned about how this has played out and also what it suggests may happen when Medicaid work requirements, which create their own set of administrative hurdles, are implemented. First, persons who are eligible for coverage should not lose coverage. Bad health outcomes will follow. Second, persons who are no longer Medicaid eligible should be guided to other options, such as subsidized ACA marketplace coverage. Finally, the variation in how states conduct Medicaid eligibility reviews leads to unfortunate inequities." What Happens Next As the unwinding continues, more reductions in enrollment are expected in California and across the country. With millions already having lost health coverage, concerns remain about access to care for low-income individuals and families.